Proudly supported by
Outline
Join Ian Baguley and Rajiv Reebye as they go head-to-head in two rounds of expert debate in an interactive symposium, chaired by Ted Wein.
Our experts will discuss important clinical questions, such as ‘are current guidelines, recommendations and screening tools enough to meet the challenges of early referral, diagnosis and treatment for our patients with post-stroke spasticity?’ and ‘once diagnosed, what strategies can we use to optimise BoNT/A treatment efficacy and track patient goal attainment?’
Who will win? It’s up to you to decide!
BoNT/A, botulinum toxin type A.
AbbVie Pty Ltd. Mascot NSW 2020 | BONT-AA-00268-E | May 2024 | v1.0
